SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504,649 | -51.4% | 2,508,585 | +5.2% | 0.00% | -33.3% |
| Q2 2023 | $3,099,169 | -1.8% | 2,383,976 | +32.9% | 0.00% | 0.0% |
| Q1 2023 | $3,156,009 | -26.9% | 1,793,187 | +30.3% | 0.00% | -40.0% |
| Q4 2022 | $4,320,104 | -26.8% | 1,375,829 | +14.2% | 0.01% | -28.6% |
| Q3 2022 | $5,902,000 | +23.3% | 1,204,632 | +4.2% | 0.01% | +16.7% |
| Q2 2022 | $4,787,000 | +9.2% | 1,156,230 | +53.2% | 0.01% | +50.0% |
| Q1 2022 | $4,385,000 | +5.4% | 754,767 | +36.1% | 0.00% | +33.3% |
| Q4 2021 | $4,161,000 | +1000.8% | 554,745 | +1223.5% | 0.00% | – |
| Q3 2021 | $378,000 | +28.1% | 41,914 | +70.1% | 0.00% | – |
| Q2 2021 | $295,000 | -67.2% | 24,645 | -65.6% | 0.00% | -100.0% |
| Q1 2021 | $899,000 | -87.1% | 71,708 | -84.0% | 0.00% | -83.3% |
| Q4 2020 | $6,976,000 | +416.4% | 447,006 | +212.6% | 0.01% | +500.0% |
| Q3 2020 | $1,351,000 | +340.1% | 143,012 | +318.0% | 0.00% | – |
| Q2 2020 | $307,000 | +320.5% | 34,215 | +197.4% | 0.00% | – |
| Q1 2020 | $73,000 | -90.3% | 11,506 | -87.2% | 0.00% | -100.0% |
| Q4 2019 | $753,000 | -7.6% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $815,000 | -15.9% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $969,000 | -62.3% | 90,000 | -66.6% | 0.00% | -66.7% |
| Q1 2019 | $2,572,000 | -37.5% | 269,575 | -24.8% | 0.00% | -40.0% |
| Q4 2018 | $4,118,000 | +148.4% | 358,688 | +266.7% | 0.01% | +150.0% |
| Q3 2018 | $1,658,000 | +733.2% | 97,812 | +598.4% | 0.00% | – |
| Q2 2018 | $199,000 | -96.8% | 14,006 | -95.8% | 0.00% | -100.0% |
| Q1 2018 | $6,273,000 | -72.0% | 330,141 | -75.8% | 0.01% | -71.0% |
| Q4 2017 | $22,375,000 | -7.0% | 1,364,295 | -15.0% | 0.03% | -16.2% |
| Q3 2017 | $24,068,000 | +144.7% | 1,604,555 | +43.6% | 0.04% | +131.2% |
| Q2 2017 | $9,834,000 | +814.8% | 1,117,522 | +440.6% | 0.02% | +700.0% |
| Q1 2017 | $1,075,000 | -2.1% | 206,704 | -42.6% | 0.00% | 0.0% |
| Q4 2016 | $1,098,000 | +56.6% | 360,038 | +137.9% | 0.00% | +100.0% |
| Q3 2016 | $701,000 | +6.7% | 151,321 | +33.4% | 0.00% | 0.0% |
| Q2 2016 | $657,000 | -19.1% | 113,406 | -15.5% | 0.00% | 0.0% |
| Q1 2016 | $812,000 | -80.5% | 134,182 | -70.6% | 0.00% | -83.3% |
| Q4 2015 | $4,166,000 | +81.3% | 456,300 | +12.0% | 0.01% | +100.0% |
| Q3 2015 | $2,298,000 | +10.3% | 407,475 | +116.9% | 0.00% | 0.0% |
| Q2 2015 | $2,084,000 | -66.8% | 187,879 | -53.1% | 0.00% | -70.0% |
| Q1 2015 | $6,286,000 | +4.0% | 400,883 | +0.8% | 0.01% | +25.0% |
| Q4 2014 | $6,046,000 | +47.8% | 397,507 | +4.8% | 0.01% | +60.0% |
| Q3 2014 | $4,091,000 | +6.1% | 379,311 | +50.3% | 0.01% | 0.0% |
| Q2 2014 | $3,855,000 | +16.2% | 252,443 | +37.6% | 0.01% | 0.0% |
| Q1 2014 | $3,317,000 | +635.5% | 183,449 | +464.8% | 0.01% | +400.0% |
| Q4 2013 | $451,000 | +134.9% | 32,479 | +77.7% | 0.00% | – |
| Q3 2013 | $192,000 | – | 18,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |